Skip to main navigation

Home
Company
Product Candidates
Science
Partnerships
- Overview
Investors & Media
Investor Relations
Careers
- Current Opportunities

Home Contact Us

Company
Product Candidates
Science
Partnerships
- Overview
Investors & Media
Header investor menu
Careers
- Current Opportunities

Event Calendar

Event Calendar

Webcasts

Date

Title

December 19, 2024

RYONCIL FDA Approval

August 29, 2024

Financial Results and Operational Update for the Period Ended June 30, 2024

February 29, 2024

Financial Results and Operational Update for the Period Ended December 31, 2023

June 9, 2022

Chronic Low Back Pain Key Opinion Leader Event

Investor Relations

At A Glance
Company Announcements
- ASX Announcements
Share Price & Tools
Events & Presentations
- Events
- Presentations
Financial Information
Shareholder Services

Tools

Print Page
RSS Feeds
Email Alerts

Share Price : as of Jan 17, 2025

Company
Product Candidates
Science
Partnerships
- Overview
Careers
- Current Opportunities
Investors & Media
Header investor menu

Copyright © 2025 Mesoblast Ltd

Disclaimer
Privacy Policy
Search